Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma.

@article{Skoner2000LongitudinalGI,
  title={Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma.},
  author={David Skoner and Stanley J Szefler and Michael Welch and Karen L Walton-Bowen and Mario Cruz-Rivera and Joseph Alexander Smith},
  journal={The Journal of allergy and clinical immunology},
  year={2000},
  volume={105 2 Pt 1},
  pages={259-68}
}
BACKGROUND Results of recent growth studies suggest that inhaled glucocorticosteroids may affect growth in children. OBJECTIVE Three 52-week, open-label extension studies (studies A, B, and C) were conducted to compare the effects of budesonide inhalation suspension (BIS) with conventional asthma therapy (CAT) on long-term safety, including intermediate-term growth, in 3 different pediatric asthma populations. METHODS Pediatric asthma patients (ages 6 months to 8 years) from 3 multicenter… CONTINUE READING